PMPRB report reveals most new medicines come to market with high treatment costs
The Patented Medicine Prices Review Board (PMPRB) published today the 7th edition of its annual Meds Entry Watch report.
Read the original at the source: https://www.canada.ca/en/patented-medicine-prices-review/news/2023/08/pmprb-report-reveals-most-new-medicines-come-to-market-with-high-treatment-costs.html
Officially imported this from Patented Medicine Prices Review Board’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Patented Medicine Prices Review Board — imported from official source
- Official source
- https://api.io.canada.ca/io-server/gc/news/en/v2?dept=patentedmedicinepricesreviewboard&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Patented%20Medicine%20Prices%20Review%20Board ATOM
- Imported
- October 03, 2026 20:43
- Versions
- 1 recorded
- Identity
https://www.canada.ca/en/patented-medicine-prices-review/news/2023/08/pmprb-report-reve...